FMR1 and fragile X syndrome: Previous work has shown that the FMR1 gene can be transiently demethylated and reactivated in FXS lymphoblastoid and fibroblast cells by treatment with 5-azadeoxycytidine (AZA), and the gene is re-silenced in approximately three weeks after removal of AZA [35, 82].